FESK.COMYour global study desk
Email us
Home › Scholar › Van-Lang Ngo
COMPILEDopen profilenot managed by this scholar
V

Van-Lang Ngo

Researcher Profile 5/10
This is my profile

Information

Featured publications

RNA therapeutics history and future perspectives3 citations
Progress in molecular biology and translational science · 2024 · DOI
KIAA1199: A Novel Regulator of Chemoresistance in Human Cancer Cells2 citations
Cancer Control · 2025 · DOI
Aldehyde Dehydrogenase-1A1 (ALDH1A1): The Novel Regulator of Chemoresistance in Pancreatic Cancer Cells2 citations
Cancer Control · 2024 · DOI
RNA therapeutics for β-thalassemia2 citations
Progress in molecular biology and translational science · 2024 · DOI
Hepatitis B virus genotypes and antiviral drug resistance mutations in treatment-naïve patients with chronic hepatitis B in Bacninh, Vietnam: a cross-sectional study2 citations
Therapeutic Advances in Infectious Disease · 2025 · DOI
Author response for "Aldehyde Dehydrogenase-1A1 (ALDH1A1): The Novel Regulator of Chemoresistance in Pancreatic Cancer Cells"
· 2024 · DOI
Author response for "Aldehyde Dehydrogenase-1A1 (ALDH1A1): The Novel Regulator of Chemoresistance in Pancreatic Cancer Cells"
· 2024 · DOI

About the field of Medicine and Pharmacy

Common research topics in this field:

Mosquito-borne diseases and controlAntibiotic Resistance in BacteriaTuberculosis Research and EpidemiologyMalaria Research and ControlCOVID-19 and Mental HealthHIV/AIDS Research and Interventions

Institutions with the most researchers in this field:

These figures count profiles currently in this directory, not nationwide statistics.

The publication list above is compiled from the open academic database OpenAlex (CC0 licence). Compare with the source record on OpenAlex ↗

Suggest / Claim this profile

  
Profile aggregated from public sources. We respect scholars' rights to edit and remove information — all requests are processed promptly.
Van-Lang NgoPhenikaa University
Claim
Original profile stored athocthuat.vn— two pages display the same database, verification syncs everywhere.